GS-441524 - HY-103586
Nur noch %1 verfügbar
Catalog #
HY-103586
Ab
21,00 €
GS-441524, predominant metabolite of Remdesivir and superior to Remdesivir against Covid-19 , shows comparable efficacy in cell-based models of primary human lung and cat cells infected with coronavirus. GS-441524 could strongly inhibits feline infectious peritonitis virus (FIPV), with an EC50 of 0.78 μM[1][2][3].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-103586/GS-441524-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | COVID-19-anti-virus |
| CAS | 1191237-69-0 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 291.26 |
| Solubility | DMSO : 83.33 mg/mL (ultrasonic) |
| Clinical Information | Phase 3 |
| Target | DNA/RNA Synthesis;SARS-CoV |
| Application: | COVID-19-anti-virus |
|---|